In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological…
In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological…
Strengthening market position Polpharma, with almost 90 years of history, is one of the largest manufacturers of medicines in Central and Eastern Europe. With the…
Polpharma, the leader of Polish pharmaceutical sector and MSN Laboratories are delighted to announce a strategic distribution partnership. Polpharma, renowned for its leadership in the…
In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological…
Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.
By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.